An assessment of iron overload in children treated for cancer and nonmalignant hematologic disorders

European Journal of Pediatrics

Volumn 173, Issue 9, 2014, Pages 1137-1146

  Rascon, Jelena ^a   Rageliene, Lina ^a   Stankeviciene, Sigita ^a   Palionis, Darius ^a   Tamosiunas, Algirdas Edvardas ^a   Valeviciene, Nomeda ^a   Zvirblis, Tadas ^a  

^a VILNIUS UNIVERSITY   (Lithuania)

Author keywords

Cancer survivors; Ferritin; Iron overload; MRI; Treatment intensity groups

Indexed keywords

FERRITIN; IRON; BIOLOGICAL MARKER; TRACE ELEMENT;

ADOLESCENT; ARTICLE; BODY WEIGHT; CHILD; ERYTHROCYTE CONCENTRATE; FERRITIN BLOOD LEVEL; FOLLOW UP; HEART EJECTION FRACTION; HEMATOLOGIC DISEASE; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HYPERFERRITINEMIA; INTENSITY OF TREATMENT RATING SCALE 3.0; IRON BLOOD LEVEL; IRON OVERLOAD; MAJOR CLINICAL STUDY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; ADVERSE EFFECTS; BLOOD; CHELATION THERAPY; COMPARATIVE STUDY; ERYTHROCYTE TRANSFUSION; FEMALE; HEMATOLOGIC DISEASES; INFANT; LONGITUDINAL STUDY; MALE; NEOPLASMS; PHYSIOLOGIC MONITORING; PRESCHOOL CHILD; PROCEDURES; PROSPECTIVE STUDY;

ADOLESCENT; BIOMARKERS; CHELATION THERAPY; CHILD; CHILD, PRESCHOOL; ERYTHROCYTE TRANSFUSION; FEMALE; FERRITINS; FOLLOW-UP STUDIES; HEMATOLOGIC DISEASES; HUMANS; INFANT; IRON; IRON OVERLOAD; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MONITORING, PHYSIOLOGIC; NEOPLASMS; PROSPECTIVE STUDIES; TRACE ELEMENTS;

EID: 84908357280     PISSN: 03406199     EISSN: 14321076     Source Type: Journal    
DOI: 10.1007/s00431-014-2295-5     Document Type: Article

References (30)

1. Alexopoulou E, Stripeli F, Baras P, Seimenis I, Kattamis A, Ladis V, Efstathopoulos E, Brountzos EN, Kelekis AD, Kelekis NL (2006) R2 relaxometry with MRI for the quantification of tissue iron overload in beta-thalassemic patients. J Magn Reson Imaging 23(2):163-170. doi:10.1002/jmri.20489 (Pubitemid 43191069)
2. Amid A, Barrowman N, Vijenthira A, Lesser P, Mandel K, Ramphal R (2013) Risk factors for hyperferritinemia secondary to red blood cell transfusions in pediatric cancer patients. Pediatr Blood Cancer 60(10):1671-1675. doi:10.1002/pbc.24629
3. Anderson LJ, Holden S, Davis B, Prescott E, Charrier CC, Bunce NH, Firmin DN, Wonke B, Porter J, Walker JM, Pennell DJ (2001) Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 22(23):2171-2179 (Pubitemid 33139463)
4. Asberg A, Thorstensen K, Mikkelsen G, Asberg AE (2013) The diagnostic accuracy of unbound iron binding capacity (UIBC) as a test for empty iron stores. Scand J Clin Lab Invest 73(3):208-213. doi:10.3109/00365513.2013.765029
5. Carpenter JP, He T, Kirk P, Roughton M, Anderson LJ, de Noronha SV, Sheppard MN, Porter JB, Walker JM, Wood JC, Galanello R, Forni G, Catani G, Matta G, Fucharoen S, Fleming A, House MJ, Black G, Firmin DN, St Pierre TG, Pennell DJ (2011) On T2* magnetic resonance and cardiac iron. Circulation 123(14):1519-1528. doi:10.1161/CIRCULATIONAHA.110.007641
6. Cianciulli P (2008) Treatment of iron overload in thalassemia. Pediatr Endocrinol Rev 6(Suppl 1):208-213
7. Cohen AR, Glimm E, Porter JB (2008) Effect of transfusional iron intake on response to chelation therapy in beta-thalassemia major. Blood 111(2):583-587. doi:10.1182/blood-2007-08-109306
8. de Ville de Goyet M, Moniotte S, Robert A, Dupont S, Vermylen C, Veyckemans F, Brichard B (2013) Iron overload in children undergoing cancer treatments. Pediatr Blood Cancer 60(12):1982-1987. doi:10.1002/pbc.24705
9. Di Tucci AA, Matta G, Deplano S, Gabbas A, Depau C, Derudas D, Caocci G, Agus A, Angelucci E (2008) Myocardial iron overload assessment by T2* magnetic resonance imaging in adult transfusion dependent patients with acquired anemias. Haematologica 93(9):1385-1388. doi:10.3324/haematol.12759
10. Eng J, Fish JD (2011) Insidious iron burden in pediatric patients with acute lymphoblastic leukemia. Pediatr Blood Cancer 56(3):368-371. doi:10.1002/pbc.22851
11. Gatta G, Zigon G, Capocaccia R, Coebergh JW, Desandes E, Kaatsch P, Pastore G, Peris-Bonet R, Stiller CA (2009) Survival of European children and young adults with cancer diagnosed 1995-2002. Eur J Cancer 45(6):992-1005. doi:10.1016/j.ejca.2008.11.042
12. Halonen P, Mattila J, Suominen P, Ruuska T, Salo MK, Makipernaa A (2003) Iron overload in children who are treated for acute lymphoblastic leukemia estimated by liver siderosis and serum iron parameters. Pediatrics 111(1):91-96 (Pubitemid 36071037)
13. Jastaniah W, Harmatz P, Pakbaz Z, Fischer R, Vichinsky E, Walters MC (2008) Transfusional iron burden and liver toxicity after bone marrow transplantation for acute myelogenous leukemia and hemoglobinopathies. Pediatr Blood Cancer 50(2):319-324. doi:10.1002/pbc.21260
14. Kazak AE, Hocking MC, Ittenbach RF, Meadows AT, Hobbie W, DeRosa BW, Leahey A, Kersun L, Reilly A (2012) A revision of the intensity of treatment rating scale: classifying the intensity of pediatric cancer treatment. Pediatr Blood Cancer 59(1):96-99. doi:10.1002/pbc.23320
15. Kirk P, Roughton M, Porter JB, Walker JM, Tanner MA, Patel J, Wu D, Taylor J, Westwood MA, Anderson LJ, Pennell DJ (2009) Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. Circulation 120(20):1961-1968. doi:10.1161/CIRCULATIONAHA.109.874487
16. Kolnagou A, Michaelides Y, Kontoghiorghe CN, Kontoghiorghes GJ (2013) The importance of spleen, spleen iron, and splenectomy for determining total body iron load, ferrikinetics, and iron toxicity in thalassemia major patients. Toxicol Mech Methods 23(1):34-41. doi:10.3109/15376516.2012.735278
17. Kwiatkowski JL, Kim HY, Thompson AA, Quinn CT, Mueller BU, Odame I, Giardina PJ, Vichinsky EP, Boudreaux JM, Cohen AR, Porter JB, Coates T, Olivieri NF, Neufeld EJ (2012) Chelation use and iron burden in North American and British thalassemia patients: a report from the Thalassemia Longitudinal Cohort. Blood 119(12):2746-2753. doi:10.1182/blood-2011-04-344507
18. Lutz K, von Komorowski G, Durken M, Engelhardt R, Dinter DJ (2008) Myocardial iron overload in transfusion-dependent pediatric patients with acute leukemia. Pediatr Blood Cancer 51(5):691-693. doi:10.1002/pbc.21663
19. Murtagh LJ, Whiley M, Wilson S, Tran H, Bassett ML (2002) Unsaturated iron binding capacity and transferrin saturation are equally reliable in detection of HFE hemochromatosis. Am J Gastroenterol 97(8):2093-2099. doi:10.1111/j.1572-0241.2002.05927.x
20. Neukirchen J, Fox F, Kundgen A, Nachtkamp K, Strupp C, Haas R, Germing U, Gattermann N (2012) Improved survival in MDS patients receiving iron chelation therapy-a matched pair analysis of 188 patients from the Dusseldorf MDS registry. Leuk Res 36(8):1067-1070. doi:10.1016/j.leukres.2012.04.006
21. Nottage K, Gurney JG, Smeltzer M, Castellanos M, Hudson MM, Hankins JS (2013) Trends in transfusion burden among long-term survivors of childhood hematological malignancies. Leuk Lymphoma 54(8):1719-1723. doi:10.3109/10428194. 2012.750724
22. Oshtrakh MI, Alenkina IV, Vinogradov AV, Konstantinova TS, Kuzmann E, Semionkin VA (2013) Mossbauer spectroscopy of the iron cores in human liver ferritin, ferritin in normal human spleen and ferritin in spleen from patient with primary myelofibrosis: preliminary results of comparative analysis. Biometals 26(2):229-239. doi:10.1007/s10534-012-9602-2
23. Reddy KS, Eng J, Carlson C, Ginsberg J, Fish J (2011) Impact of transfusional support for childhood cancer-peering behind the iron curtain. Pediatr Blood Cancer 56:908
24. Roche DIA customer self-service portal. https://cssportal.roche.com/eld/ lt/lt/DocumentResult/ResultList. Accessed 10 Aug 2013
25. Ruccione KS, Mudambi K, Sposto R, Fridey J, Ghazarossian S, Freyer DR (2012) Association of projected transfusional iron burden with treatment intensity in childhood cancer survivors. Pediatr Blood Cancer 59(4):697-702. doi:10.1002/pbc.24046
26. St Pierre TG, Clark PR, Chua-anusorn W, Fleming AJ, Jeffrey GP, Olynyk JK, Pootrakul P, Robins E, Lindeman R (2005) Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood 105(2):855-861. doi:10.1182/blood-2004-01-0177 (Pubitemid 40070775)
27. Taher AT, Musallam KM, Karimi M, Cappellini MD (2012) Contemporary approaches to treatment of beta-thalassemia intermedia. Blood Rev 26(Suppl 1):S24-27. doi:10.1016/S0268-960X(12)70008-5
28. Voskaridou E, Douskou M, Terpos E, Papassotiriou I, Stamoulakatou A, Ourailidis A, Loutradi A, Loukopoulos D (2004) Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease. Br J Haematol 126(5):736-742. doi:10.1111/j.1365-2141.2004.05104.x (Pubitemid 39221312)
29. Wood JC, Enriquez C, Ghugre N, Tyzka JM, Carson S, Nelson MD, Coates TD (2005) MRI R2 and R2*mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood 106(4):1460-1465. doi:10.1182/blood-2004-10-3982 (Pubitemid 41129616)
30. Wood JC, Origa R, Agus A, Matta G, Coates TD, Galanello R (2008) Onset of cardiac iron loading in pediatric patients with thalassemia major. Haematologica 93(6):917-920. doi:10.3324/haematol.12513 (Pubitemid 351821730)